Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.1B | 4.0B | 4.2B | 3.8B |
Cost of revenue | 1.8B | 1.7B | 1.7B | 1.6B |
Gross profit | 2.3B | 2.3B | 2.5B | 2.2B |
Operating expense | ||||
Research & development | 517M | 491M | 492M | 498M |
Selling general and admin | 472M | 446M | 428M | 465M |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.4B | 1.6B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 128M | 130M | 131M | 131M |
Other income expense | 80M | 112M | 131M | 130M |
Pretax income | 1.3B | 1.4B | 1.6B | 1.2B |
Tax provision | 97M | 154M | 192M | 120M |
Net income | 1.2B | 1.2B | 1.4B | 1.1B |
Basic EPS | 1.3 | 1.3 | 1.5 | 1.2 |
Diluted EPS | 1.3 | 1.3 | 1.5 | 1.2 |
Basic average shares | 910M | 912M | 913M | 912M |
Diluted average shares | 916M | 919M | 920M | 919M |
EBITDA | 1.8B | 1.9B | 2.1B | 1.8B |
Net income from continuing op. | 1.2B | 1.2B | 1.4B | 1.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | 6M | 7M | — |